Author Archives: admin001

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia

BERKELEY, Calif., and VANCOUVER, British Columbia, September 16, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49

BERKELEY, Calif., and VANCOUVER, British Columbia, September 9, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 27, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Richard J. Berman to Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, August 12, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces $350,000 Equity Investment by Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, July 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

BERKELEY, Calif., and VANCOUVER, British Columbia, May 28, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders

BERKELEY, Calif., and VANCOUVER, British Columbia, May 13, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston

BERKELEY, Calif., and VANCOUVER, British Columbia, April 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity

• As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy ...

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte

· BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the ...